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Abstract The etiology of most central nervous system
(CNS) malformations remains unknown. We have utilized
the fact that autosomal chromosome aberrations are com-
monly associated with CNS malformations to identify new
causative gene loci. The human cytogenetic database, a
computerized catalog of the clinical phenotypes associated
with cytogenetically detectable human chromosome aberra-
tions, was used to identify patients with 14 selected brain
malformations including 541 with deletions, and 290 carry-
ing duplications. These cases were used to develop an auto-
somal deletion and duplication map consisting of 67
diVerent deleted malformation associated bands (MABs) in
55 regions and 88 diVerent duplicated MABs in 36 regions;
31 of the deleted and 8 duplicated MABs were highly sig-
niWcantly associated (P < 0.001). All holoprosencephaly
MABs found in the database contained a known HPE gene
providing some level of validation for the approach. SigniW-
cantly associated MABs are discussed for each malforma-
tion together with the published data about known disease-
causing genes and reported malformation-associated loci, as
well as the limitations of the proposed approach.
Introduction
Congenital malformations of the CNS are common birth
defects with a birth prevalence of about 1% (Arvanitis
1999). Although mutations have been identiWed in more
than 37 diVerent genes in CNS malformations (Sarnat
2005) the etiology of the majority of cases remains
unknown. For example, in holoprosencephaly (HPE) every
identiWed mutation in known HPE-associated genes occurs
in less than 4% of cases, and almost all of those are spo-
radic. (Cohen 2004). The Human malformation map has
been updated recently (Carey and Viskochil 2007), how-
ever, only some of the brain malformations discussed here
are included (HPE, lissencephaly and Dandy–Walker mal-
formation).
Chromosome aberrations provide us with an important
clue for the location of genes involved in congenital
defects, since clinical and molecular cytogenetic data can
be used to identify regions highly associated with birth
defect of interest. A Wrst analysis of the association of
chromosomal imbalance with congenital malformations
based on clinical and cytogenetic data has been performed
in 1998 (Brewer et al. 1998, 1999). Many and especially
frequent CNS malformations are common in autosomal
chromosome aberrations (Schinzel 2001). In this work,
we focus on the delineation of gene loci signiWcantly
associated with speciWc brain malformations using an
unpublished updated version of the database which
includes about 3000 additional entries. As the latter stem
from more recent publications (after 1994), the breakpoint
determination can be considered more precise and reliable
as compared to the cases used in the aforementioned
study.
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Case selection
The human cytogenetic database (HCD) is an expertly
curated computerized catalog of postnatally ascertained,
cytogenetically detectable human chromosome aberrations.
The Wrst edition of HCD was published in 1994 (Human
Cytogenetics Database 1994). A recent version of HCD
contains more than 9,200 published cases with over 2,800
diVerent aberrations (unpublished data). A search of HCD
was performed for the brain malformations shown in
Table 1. The selection was determined by the search mode
of HCD (identical to London Dysmorphology Database).
We excluded brain abnormalities not common in chromo-
somal aberrations (such as brain tumors, vascular abnor-
malities, hamartomas, neuronal migration abnormality),
abnormalities which are unspeciWc and likely to have envi-
ronmental causes (such as cerebral atrophy and intracranial
calciWcation), and generalized terms (such as pons/medulla/
basal ganglia/abnormal).
Cytogenetic and clinical data on individuals with non-
mosaic simple deletions/duplications (those involving a
single contiguous region of autosomal DNA) were
extracted. Complex rearrangements were excluded to avoid
any modifying eVects (Lurie 1993). The International Sys-
tem for Human Cytogenetic Nomenclature (ShaVer and
Tommerup 2005), 400-band nomenclature, was used to
describe the deletions/duplications. A 400-band level was
chosen taking into account that HCD contained cases since
1962, when high resolution banding technique did not exist.
Deletions/duplications involving subbands were scored as
including the whole band, breakpoints bands were scored as
deleted/duplicated.
Statistical analysis
For the 14 malformation entities studied, the observed
number of deletions/duplications of a particular band was
compared with the expected number calculated from the
band distribution of all band deletions/duplications (Brewer
et al. 1998, 1999). The Fisher exact test was used to evalu-
ate an association between deletion/duplication in a parti-
cular band and presence of a malformation (SPSS 13, Inc.,
Chicago). Chromosomal bands found to be signiWcantly
associated (P < 0.05) with a given malformation, so called
malformation-associated bands (MABs) (Brewer et al.
1998), were subdivided into three groups according to the
P value: (1) P < 0.05, (2) P < 0.01, P > 0.001 and (3)
P < 0.001.
Validation of bands and regions
A systematic analysis of all published array-CGH studies
was performed to deWne cases with the malformations of
interest.
The candidate gene approach was used to identify genes
hemizygosity of which can result in brain malformation.
The list of genes localized on the bands found to be signiW-
cantly associated with brain defects that were not previ-
ously reported were downloaded from Entrez Genome
View (http://www.ncbi.nlm.nih.gov/mapview/map_search.
cgi; access July 2006). Candidates were selected according
to known biological function, pattern of tissue expression,
similar malformations in knockout organisms.
Results
Identifying MABs
Three thousand one hundred and eighty nine cases with
simple autosomal deletions and 2,178 cases with simple
autosomal duplications were identiWed in the HCD. Five
hundred and forty one patients with deletions and 290 with
duplications were cataloged as having one of the 14 brain
malformations chosen for the study. Schizencephaly (0
cases), pachygyria (4 cases) and aqueductus stenosis (1
case) had to be excluded because the number of cases asso-
ciated with simple deletions and duplications was too small
for useful analysis. The group of cerebellar anomalies was
also excluded due to poor clinical deWnition (doubtful
results of the investigations, lack of MRI, etc.).
SigniWcant associations were found for 67 diVerent
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Hum Genet (2008) 124:73–80 75regions and 88 diVerent duplicated MABs in 36 regions; 31
of the deleted and 8 duplicated MABs were highly signiW-
cantly associated (P < 0.001) (Tables 2, 3).
The distribution of aberrations throughout the autosomes
was not random. Deletions of chromosome 12, 16, 19 and
21 were not associated with any of the brain malformations
studied.
Further delineation of MABs
In order to narrow down candidate chromosome regions, all
published array-CGH and larger subtelomere FISH studies
were analyzed to deWne cases with the malformations of
interest. From 2001 to 2006 eight studies (a total of 575
patients with mental retardation) have been published
Table 2 Deleted regions signiWcantly associated with brain malformations
Malformation No. of 
cases
All MABs (P < 0.05) MABs (P < 0.01, 
P > 0.001)
MABs (P < 0.001)
Holoprosencephaly 111 2p23, 2p22, 2p21, 7q32-q36, 
13q22-13q34, 18p11.3-11.1
13q22 2p22, 2p21, 7q32-q36, 
13q31-q34, 18p11.3-11.1
Cyclopia 5 2p23-p21, 18p11.3-p11.1 2p22-p21
Premaxillary agenesis 6 18p11.3-p11.1 18p11.3-p11.1
Dandy-Walker malformation 18 3q25-q26.3, 6p25-p23 3q25 3q26.1-q26.3, 6p25, 6p24
Agenesis of corpus callosum 145 1q42-q44, 2p22, 2q13-q14.3, 2q21, 
3q13.1-q21, 4q21, 6q25-q26 





Anencephaly 4 13q31-q34 13q32-q34
Neural tube defects 
(without anencephaly)
84 1q42-q44, 2q36, 13q22-q34 1q43, 2q36 13q22-q32, 13q33-q34
Anterior encephalocele 4 1q43-q44, 11p12-p11.2 1q43-q44
Posterior encephalocele 15 1q41-q44, 2q24-q31, 13q22-q34 1q42-q44, 2q24, 13q22 13q31-q34
Meningocele/spina biWda 16 1q43-q44, 2q35-q36, 22q11.2 1q43, 2q36, 2q11.2 2q35-q36
Spina biWda occulta 51 4p15.2-p15.1, 9q22 13q31-q34, 20p13 13q33
Lissencephaly 26 14q11.2-q13, 17p13, 22q12 14q11.2-q13, 17p13
Arnold-Chiari malformation 7 1q23-q24, 1q31, 2q35-q36, 5q23, 6q21 2q35-q36
Table 3 Duplicated regions signiWcantly associated with brain malformations
Malformation No. of 
cases




Holoprosencephaly 34 3p26-p21, 3q11.1, 3q11,2, 3q23, 3q29, 
5q32-q34, 6p25-p21.1, 13q14-q34
3p24-p22, 6p21.2-p21.1 3p26, 3p25
Cyclopia 1 3p26-p22
Premaxillary agenesis 4 5q32-q34
Dandy-Walker malform. 15 12q24.3, 17q21, 17q22
Agenesis of corpus callosum 73 1p32, 6p21.3-p21.1, 8p23-p11.1 8p23 8p22, 8p21
Anencephaly 9 2p25-p22 2p25-p22
Neural tube defects 
(without anencephaly)
49 1q43-q44, 2p16-p13, 20p13-p11.1
Anterior encephalocele 3 1q11-q24, 7p12-q11.1




Spina biWda occulta 37 4p13-p11, 20p13-p11.1
Lissencephaly 0
Arnold-Chiari malform. 1 5p15.3-p11
Aqueduct stenosis 5 17p13123
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were performed (de Vries et al. 2005; Joly et al. 2001;
Menten et al. 2006; Poss et al. 2006; Rosenberg et al. 2006;
Schoumans et al. 2005; Shaw-Smith et al. 2004; Tyson
et al. 2005). Surprisingly, only a few patients with cryptic
chromosomal aberrations were described with brain mal-
formations, most often Agenesis of corpus callosum (ACC)
and Dandy–Walker malfromation. All but one rearrange-
ment diVered from the MABs determined in our study.
Rosenberg et al. (2006) reported an aCGH investigation of
81 patients with mild to severe mental retardation and one
of the patients with a de novo del(13)(q32.3) was found to
have ACC, which corresponds to ACC and HPE associated
MABs determined in our study.
IdentiWcation of candidate genes
Two interesting malformation-associated loci were selected
for candidate gene identiWcation. 3q13.3 is signiWcantly
associated with ACC, and 1q42-q44 is associated with both
ACC and NTD. 55 genes map within 3q13.3 and 294
within 1q42-q44 (Entrez Genome View, access July 2006).
Pseudogenes and genes with unknown function not
expressed in neural tissue were excluded from further
analysis. Genes of unknown function but expressed in
neural tissue during embryonic development have been
considered as genes with possible involvement, along with
genes taking part in diVerent pathways known to be impor-
tant during CNS embryogenesis (Tables 4, 5).
Table 4 Possible candidate 
genes for agenesis of corpus 
callosum and neural tube defects
Possible candidate genes Reference
1q42-q44
WNT3A, wingless-type MMTV integration site family, 
member 3A
Gunhaga et al. (2003)
RHOU, ras homolog gene family, member U Kirikoshi and Katoh (2002)
DISC1, disrupted in schizophrenia 1 Morris et al. (2003)
Ozeki et al. (2003)
GNG4, guanine nucleotide binding protein (G protein), 
gamma 4
Ray et al. (1995)
FMN2, formin 2 Leader and Leder (2000)
GREM2, gremlin 2, cysteine knot superfamily, 
homolog (Xenopus laevis)
Avsian-Kretchmer and Hsueh (2004)
OPN3, opsin 3 (encephalopsin, panopsin) Halford et al. (2001)
ZNF238,  zinc Wnger protein 238 Becker et al. (1997)
3q13.3
GAP43,  growth associated protein 43 Strittmatter et al. (1995)
GPR156, G protein-coupled receptor 156 Calver et al. (2003)
RABL3 RAB, member of RAS oncogene family-like 3 Strausberg et al. (2002)
FBXO40, F-box protein 40 Nagase et al. (1999)
LSAMP, limbic system-associated membrane protein Pimenta et al. (1996)
Table 5 Strong candidate genes for agenesis of corpus callosum and neural tube defects




3q13.3 CDGAP, Cdc42 GTPase-activating protein GTPase activator; expressed in the corpus callosum 
and fetal brain (Nagase et al. 1999)
3q13.3 IGSF11, immunoglobulin superfamily, member 11 Cell adhesion molecule; expressed in commissure Wbers 
of the corpus callosum (Harada et al. 2005; Suzu et al. 2002)
1q42* DISPA, dispatched homolog 1 Integral membrane protein; plays an essential role in Hh 
patterning activities in Drosophila; Cephalic defects 
in knock-out mice are reminiscent of holoprosencephaly, 
embryos display also neural tube patterning defects (Ma et al. 2002)123
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Human autosomal aberrations are characterized by a com-
bination of non-speciWc phenotypic eVects, such as intra-
uterine and postnatal growth retardation, craniofacial
dysmorphisms, and impaired mental development (Schinzel
2001). Malformations are also common but it is rare for
speciWc malformations to be invariably associated with a
speciWc chromosome aberration. However, clinically recog-
nizable chromosomal syndromes (Wolf–Hirschhorn syn-
drome, Cri du Chat syndrome, Down syndrome, Cat Eye
syndrome etc.) suggest that hemizygosity or duplication of
some of the aVected genes have a direct negative eVect on a
particular developmental process. Consequently the recog-
nition of a signiWcant association between a congenital mal-
formation and deletion or duplication of a speciWc locus
may help in the identiWcation of causative genes. The Wrst
systematic analysis of clinical and cytogenetic information
associated with a large number of autosomal deletions and
duplications was made by Brewer et al. (1998, 1999) to
construct a chromosomal map showing association of con-
genital malformations and chromosomal regions. In the last
10 years HCD has doubled the number of cases available
for statistical analysis and here we identify new MABs for
an important group of malformations. It was gratifying to
note that all the holoprosencephaly (HPE) deleted MABs
identiWed in this study contained a known causative gene
for HPE (Table 2; 2p21–SIX2 gene, 7q36–SHH gene,
13q32–ZIC2 gene, and 18p11.3–TGIF gene). HPE is a mal-
formation representing a developmental Weld defect of
impaired midline cleavage of the embryonic forebrain
(Cohen 2001) Unsurprisingly, cyclopia and premaxillary
agenesis were associated with HPE deletion MABs,
(2)(p23-p21) and (18)(p11.1-p11.3), and are assumed to be
caused by hemizygosity of the SIX2 (2p21) and TGIF
(18p11.3) genes.
Intragenic mutations mimicking haploinsuYciency are
common in human genetics. Duplication is assumed to
result in overexpression of the genes within a duplicated
region. This is not an eVect commonly mimicked by intra-
genic mutation and it is thus more diYcult to assign patho-
genesis to individual genes without animal model clues.
Overexpression of PAX6 causes eye malformations in
transgenic mice (Schedl et al. 1996), and eye abnormalities
were also reported in patients carrying a duplication inclu-
ding the PAX6 locus on 11p13 (Aalfs et al. 1997) Several
HPE duplication MABs were found (Table 3). Six patients
from HCD were reported to have dup(3p) including MABs
3p25-p26 (P < 0.001). However they all were associated
with terminal monosomies. HPE has not been mapped to
3p25-p26 previously and was only discussed as an occa-
sional Wnding in patients with dup3(pter-p21) (Schinzel
2001). In our study all but one duplications found to be
signiWcantly associated with HPE represent chromosomal
rearrangements resulting from familial translocations. All
of these are associated with terminal deletions. The loss of
the terminal regions in these cases was previously esti-
mated to be insigniWcant; therefore the cases were regis-
tered as isolated duplications. However, increasing
knowledge of the structure of subtelomeric and telomeric
regions makes it necessary to analyze the possible impact
of combined monosomies. Nevertheless, 3p25-p26 could
be a new locus for HPE genes. It was not surprising to iden-
tify duplicated MABs on chromosome 13 as this is a char-
acteristic malformation found to be associated with trisomy
13. However, the aberrations in four of Wve cases with
duplications including MABs 13q14-q34 are not pure aber-
rations (associated with terminal deletions as explained
above). Although it is diYcult to conclude that either HPE
is caused by dup(13q) or that the modifying eVects of com-
bined rearrangements play a crucial role, we consider that
overexpression of genes located on chromosome 13 may
cause HPE.
Dandy Walker malformation (DWM) is characterized by
hypoplasia and upward rotation of the cerebellar vermis
accompanied by a retrocerebellar cyst which is in commu-
nication with the fourth ventricle (Patel and Barkovich
2002). The four highly signiWcant MABs 3q26.1, 3q26.2
and 3q26.3 (P < 0.001) and 3q25 (P < 0.01, P > 0.001)
(clinical descriptions (Sudha et al. 2001; Willner et al.
1990)) are likely to represent a single locus; indeed, an
association of 3q deletions (3q24.3-q25.33) and DWM has
been previously shown. ZIC1 and ZIC4 have been sug-
gested as possible causative genes (Grinberg et al. 2004).
A second highly signiWcant region (P < 0.001) associated
with DWM found in our study is 6p25-p24 which has also
been reported (Kelly et al. 1989; Klein et al. 2005; Lin et al.
2005; Mirza et al. 2004), however, no causative gene or
genes in that region has/have been identiWed to date.
Neural tube defects are a group of malformations repre-
senting the non-closure of the neural tube resulting in an
open or close defect of the cranium or the spine (Panteliadis
and Pantzaris 1999). We showed a strong association with
anencephaly for 13q22-q34 (P < 0.0001). Brown et al.
(1993) deWned a critical region in 13q32; however, Luo
et al. (2000) questioned this Wnding and suggested deletion
in 13q33-q34 as suYcient to cause an NTD. ZIC2 and ZIC5
are considered strong candidate genes for neural tube
defects. However, no mutations have yet been described for
these genes in humans (Grinberg and Millen 2005). 1q42-
q44 was identiWed as a highly signiWcant region (P < 0.001)
for NTD as would be predicted from the known clinical
syndrome associated with this deletion. Both deletions and
duplications of (20)(p13-p11.1) show signiWcant associa-
tion with spina biWda occulta. OVOL2 (ovo like 2) maps to
this region. Murine embryos lacking Ovol2 expression123
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evidence for a relationship between spina biWda occulta and
open neural tube defects at least in a proportion of cases.
Deletions of 17p13 encompassing LIS1, and loss-of-
function mutations in LIS1 both cause lissencephaly
(Ledbetter et al. 1992; Lo Nigro et al. 1997). Thus, it has
not been a surprise to identify 17p13 as MAB with the
strongest association with lissencephaly (P < 2 £ 10¡50).
Agenesis of corpus callosum (ACC) is one of the most
frequent human CNS malformations (Bedeschi et al. 2006).
The association of ACC with chromosome aberrations has
been discussed elsewhere. Schinzel (2001) considered ACC
among selected malformations which are particularly com-
mon in autosomal chromosome aberrations. The role of
del(1)(q44), del(2q), del(6)(q25), del(15)(q15) and
dup(8)(p23-p21) in the origin of ACC is well-known
(Bedeschi et al. 2006; Dobyns 1996; Pirola et al. 1998).
One of the best documented chromosomal rearrangements
associated with ACC is del(4)(p16), or Wolf-Hirschhorn
syndrome. There were 16 cases of isolated del(4)(p16), but
taking into account the extreme phenotypic variability of
the syndrome (ACC was reported only in 6% of all regis-
tered cases), no statistically signiWcant association could be
shown. The low frequency of ACC is partly due to the fact
that MRI of the brain is often not performed in patients with
del(4)(p16), considering the poor survival and performance
of the patients and that the investigation would be of no
beneWt for them.
The strongest association with ACC has been identiWed
for del(1)(q42-q44) (P < 0.0001). The relevance of this
region for harboring an ACC gene search is well known
(Gentile et al. 2003; Murayama et al. 1991). The possible
involvement of the same gene(s) for NTD and ACC may be
embryologically plausible. The fact that the Wber commis-
sures connecting the right and the left cerebral hemispheres
form from thickening at the cranial end of the telencepha-
lon, which represents the zone of Wnal neuropore closure
(Larsen 2001), could support the assumption that these two
processes are under control of genes which regulate the
development of this particular region. Hemizygosity of the
DISPA gene might be responsible for CNS malformation in
case of 1q42 deletion. Mice embryos lacking mDispA func-
tion display the cephalic defects which are reminiscent of
HPE and also neural tube patterning defects (Ma et al.
2002). This corresponds to our results showing the associa-
tion of the DISPA region to both malformations in humans,
assuming that ACC could be a part of the HPE spectrum
(Cohen 2001). The smallest region of overlap (1,7 Mb)
including the DISPA gene was newly identiWed in 7
patients with 1q41-1q42 deletions, although none of the
reported patients had any brain abnormality (ShaVer et al.
2007). A 3,5-Mb critical region for microcephaly and ACC
in 1q44 extending from RP11-80B9 to RP11-241M7 has
recently been deWned (Boland et al. 2007), and two candi-
dates genes have been proposed. Taking into account a
variety of brain malformations in 1q42-1q44 deletions,
several genes in this region might be involved in brain
development.
3q13.3 has not been previously speciWcally discussed as
a candidate locus of ACC causative genes in any review
article. IGSF11 (immunoglobulin superfamily, member 11)
is the strongest candidate gene for ACC in 3q13.3 as it is
expressed in the commissure Wbers of the corpus callosum
(Suzu et al. 2002). CDGAP gene (Cdc42 GTPase- activat-
ing protein) is also expressed in the corpus callosum and
the fetal brain (Nagase et al. 1999). The important role of
the genes located on 3q13.3 was currently supported by
Lawson-Yuen et al. (2006). They reported a patient carry-
ing a 3q13.3 deletion with complete agenesis of corpus
callosum and provide a review of the literature with one
further case of 3q13.3 deletions and ACC (Lawson-Yuen
et al. 2006).
This approach to identify malformation loci has limita-
tions. First, the quality and completeness of the cytogenetic
and clinical descriptions in original publications is not uni-
form which concerns also recent array-CGH studies.
Second, the statistical analysis assumes that each chromo-
some band can be treated equally. However, breakpoints
involved in rearrangements are not randomly distributed
and the role of predisposing low-copy repeats contributing
to this disparity has been widely discussed (Shaw and
Lupski 2004). This “clustering” phenomenon may reduce
the resolution of chromosomal maps rather than cause an
identiWcation of false loci (Brewer et al. 1999). Third, if a
disease causing gene locus is close to or even overlaps with
a haplolethal region, it will not be detected with the strategy
chosen. Fourth, the completeness of ascertainment of
uncomplicated aberrations in the database is not known.
Furthermore, the design of this study did not include cases
with double imbalance and therefore defects occurring due
to interaction of several genes (or one gene and one or
several controlling elements) could not be detected. Finally,
it has to be emphasized that this method would not be
expected to reliably identify the locations of recessive
genes and would not identify disease genes acting via other
mechanisms of genetic dominance (Brewer et al. 1998;
Wilkie 1994). With an increasing number of submicro-
scopic deletions and duplications being identiWed it is
expected that the utility of this approach will markedly
improve.
In summary, this deletion/duplication map of human
brain malformations has identiWed several new candidate
loci and conWrmed many others. We have suggested two
new candidate genes for Agenesis of corpus callosum. The
1q42 locus has been shown to be highly signiWcant for both
Agenesis of corpus callosum and Neural tube defects.123
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